News
FDA approves a new oral treatment for some advanced breast cancers
The FDA approved giredestrant with everolimus for adults with certain previously treated cancers and authorized a blood test to check eligibility.
November 16, 2026 · 2 min read
The latest reporting, guides and features on Cancer Treatment.
The FDA approved giredestrant with everolimus for adults with certain previously treated cancers and authorized a blood test to check eligibility.



